Outset Medical Financials

OM Stock  USD 0.55  0.03  5.17%   
Outset Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Outset Medical's Non Current Assets Total are very stable compared to the past year. As of the 19th of March 2025, Non Currrent Assets Other is likely to grow to about 5.8 M, while Total Current Liabilities is likely to drop about 43.4 M. Key indicators impacting Outset Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio8.355.6904
Way Up
Slightly volatile
The essential information of the day-to-day investment outlook for Outset Medical includes many different criteria found on its balance sheet. An individual investor should monitor Outset Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Outset Medical.

Net Income

(134.37 Million)

  

Outset Medical Stock Summary

Outset Medical competes with Clearpoint Neuro, Inspire Medical, Nevro Corp, Si Bone, and Sight Sciences. Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Outset Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 444 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS6901451079
CUSIP690145107
LocationCalifornia; U.S.A
Business Address3052 Orchard Drive,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.outsetmedical.com
Phone669 231 8200
CurrencyUSD - US Dollar

Outset Medical Key Financial Ratios

Outset Medical Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets403.8M463.5M400.1M313.8M275.8M329.5M
Other Current Liab26.8M41.3M40.0M36.2M27.0M29.7M
Other Liab351K810K1.0M264K303.6K572.2K
Net Tangible Assets(372.2M)328.6M374.1M246.0M282.9M297.0M
Net Debt(256.4M)(144.5M)30.0M67.7M(119.5M)(125.5M)
Retained Earnings(494.1M)(626.0M)(789.0M)(961.7M)(1.1B)(1.0B)
Accounts Payable4.9M1.8M603K5.8M3.9M2.9M
Cash295.0M182.3M73.2M68.5M124.0M127.8M
Other Assets825K34.7M33.5M4.5M5.1M4.9M
Long Term Debt29.7M29.8M96.3M130.1M197.4M207.2M
Net Receivables6.5M25.6M28.1M33.0M35.6M21.0M
Inventory18.4M39.2M51.5M49.2M59.4M35.4M
Other Current Assets12.4M11.1M6.6M5.7M4.5M6.6M
Total Liab75.2M89.4M154.1M190.9M249.0M189.5M
Net Invested Capital358.3M403.8M342.3M253.0M224.2M153.8M
Total Current Assets345.9M409.8M373.6M291.2M258.2M299.5M
Capital Stock43K47K48K50K53K38.2K
Net Working Capital309.2M358.1M321.7M235.9M212.8M256.1M
Short Term Debt1.8M2.3M2.6M1.6M1.8M2.1M
Common Stock43K47K48K50K53K38.2K

Outset Medical Key Income Statement Accounts

202020212022202320242025 (projected)
Tax Provision39K199K295K523K491K250.2K
Net Interest Income(2.4M)(1.2M)(275K)(2.5M)(14.1M)(13.4M)
Interest Income526K498K3.3M10.2M9.8M10.2M
Interest Expense2.4M1.7M3.6M12.7M23.9M25.1M
Total Revenue49.9M102.6M115.4M130.4M113.7M83.1M
Gross Profit(13.0M)7.6M17.8M29M38.6M40.5M
Operating Income(117.5M)(130.5M)(161.0M)(169.8M)(113.4M)(119.0M)
Ebit(117.5M)(131.0M)(159.1M)(159.6M)(103.6M)(108.8M)
Research Development28.9M36.7M48.9M57.3M38.4M40.3M
Ebitda(114.3M)(124.9M)(152.8M)(153.8M)(97.9M)(102.8M)
Cost Of Revenue63.0M95.0M97.5M101.4M75.1M74.3M
Income Before Tax(121.5M)(131.7M)(162.7M)(172.3M)(127.5M)(133.9M)
Net Income(120.7M)(131.9M)(163.0M)(172.8M)(128.0M)(134.4M)
Income Tax Expense(794K)199K295K523K491K515.6K

Outset Medical Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(16.3M)(22.0M)(14.7M)1.6M(10.9M)(11.4M)
Investments3.9M(142.5M)(66.3M)7.9M103.9M109.1M
Change In Cash290.6M(112.6M)(139.1M)(4.7M)55.5M58.3M
Free Cash Flow(108.1M)(133.4M)(154.1M)(134.8M)(117.2M)(123.1M)
Depreciation3.2M5.2M5.2M5.8M5.7M4.4M
Other Non Cash Items1.2M1.6M6.0M(2.2M)31.6M33.2M
Capital Expenditures9.1M3.1M8.3M3.4M912K866.4K
Net Income(121.5M)(131.9M)(163.0M)(172.8M)(128.0M)(134.4M)
End Period Cash Flow328.3M215.7M76.5M71.8M127.3M140.0M
Change To Netincome(1.9M)25.2M1.7M31.6M36.3M38.1M

Outset Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Outset Medical's current stock value. Our valuation model uses many indicators to compare Outset Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Outset Medical competition to find correlations between indicators driving Outset Medical's intrinsic value. More Info.
Outset Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Outset Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Outset Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Outset Medical Systematic Risk

Outset Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Outset Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Outset Medical correlated with the market. If Beta is less than 0 Outset Medical generally moves in the opposite direction as compared to the market. If Outset Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Outset Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Outset Medical is generally in the same direction as the market. If Beta > 1 Outset Medical moves generally in the same direction as, but more than the movement of the benchmark.

Outset Medical Thematic Clasifications

Outset Medical is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Medical EquipmentView
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Outset Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Outset Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Outset Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0146

At this time, Outset Medical's Price Earnings To Growth Ratio is very stable compared to the past year.

Outset Medical March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Outset Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Outset Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Outset Medical based on widely used predictive technical indicators. In general, we focus on analyzing Outset Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Outset Medical's daily price indicators and compare them against related drivers.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.188
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.23)
Return On Equity
(1.71)
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.